Tradestie Institutional Equity Comparison Engine
USPH vs PDX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
USPH Overall Edge
USPH Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to US Physical Therapy Inc (USPH) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, USPH trades at 29.6x Forward P/E with 10.2% operating margin (+13.1% YoY revenue) versus PDX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, USPH sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PDX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
USPH
USPH 29.6x vs PDX N/M Fwd P/E
Growth & Margin Winner
USPH
Op Margin 10.2% vs N/A ยท YoY +13.1% vs N/A
Momentum & Technical Winner
USPH
1Y +39.8% vs -7.7% ยท 52W Pos 95% vs 42%
Options & Structure Winner
USPH
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
USPH
NYSE
US Physical Therapy Inc
Services-Health Services
$99.55
-0.05% 1D
Market Cap
$1.5B
1M Return
+16.15%
1Y Return
+39.78%
Forward P/E
29.6x
Unified AI Score
31.8 / 100
SELL
Tech 50.0
Fund 25.0
Flow 50.0
Mom 30.0
PDX
NYSE
PIMCO Dynamic Income Strategy Fund
Institutional Equity
$20.06
-0.5% 1D
Market Cap
$1.1B
1M Return
+0.2%
1Y Return
-7.69%
Forward P/E
N/M
Unified AI Score
45.3 / 100
HOLD
Tech 41.0
Fund 48.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
USPH +39.78%
PDX -7.69%
Spread: +47.47 pp (USPH Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
USPH TTM Op. Margin: 10.2%
PDX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on USPH vs PDX. Trailing 12-month operating profitability (USPH 10.2% vs PDX N/A) and valuation multiples (USPH 29.6x vs PDX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | USPH | PDX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.5B | $1.1B | Larger Scale | USPH |
| Trailing P/E Ratio Valuation | 32.9x | N/M | Lower Multiple | USPH |
| Forward P/E Ratio Valuation | 29.6x | N/M | Lower Multiple | USPH |
| Revenue Growth (YoY) Growth | +13.1% | N/A | Higher Growth | USPH |
| Operating Margin (TTM) Profitability | 10.2% | N/A | Higher Margin | USPH |
| Net Profit Margin Profitability | 3.6% | N/A | Higher Margin | USPH |
| Return on Equity (ROE) Capital Efficiency | 6.3% | N/A | Higher ROE | USPH |
| 52-Week Range Position Momentum | 95% ($58โ$102) | 42% ($18โ$22) | Stronger Trend | USPH |
| Beta / 30D Volatility Risk Regime | 0.14ฮฒ ยท 42% Vol | 0.19ฮฒ ยท 16% Vol | Lower Realized Risk | PDX |
| Unified Institutional Score Composite Signal | 31.8 / 100 (SELL) | 45.3 / 100 (HOLD) | Higher Composite | PDX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full USPH vs PDX Buy Guide
USPH
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
<1st %ile
IV Regime
Compressed (<25th %ile)
PDX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither USPH nor PDX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.